tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market

VYNE Therapeutics (VYNE) Income Statement

Compare
1,829 Followers

VYNE Therapeutics Income Statement

Last quarter (Q4 2024), VYNE Therapeutics's total revenue was $84.00K, an increase of 10.53% from the same quarter last year. In Q4, VYNE Therapeutics's net income was $-12.02M. See VYNE Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 501.00K$ 424.00K$ 477.00K$ 14.76M$ 20.99M
Gross Profit
$ 501.00K$ 424.00K$ 477.00K$ 11.41M$ 19.60M
Operating Expenses
$ 44.14M$ 29.68M$ 34.77M$ 79.44M$ 133.08M
Depreciation and Amortization
$ 4.00K$ 0.00$ 72.00K$ 109.00K$ 341.00K
EBITDA
$ -43.63M$ -29.26M$ -34.22M$ -38.94M$ -251.09M
Operating Income
$ -43.64M$ -29.26M$ -34.30M$ -68.03M$ -113.47M
Other Income/Expenses
$ 3.83M$ 1.39M$ 363.00K$ -5.75M$ -142.35M
Pretax Income
$ -39.80M$ -27.87M$ -33.93M$ -73.78M$ -255.83M
Net Income
$ -39.83M$ -28.45M$ -33.95M$ -73.33M$ -255.57M
Per Share Metrics
Basic EPS
$ -0.94$ -2.77$ -10.65$ -25.65$ -141.90
Diluted EPS
$ -0.94$ -2.77$ -10.65$ -25.65$ -141.90
Weighted Average Shares Outstanding
42.59M 10.27M 3.19M 2.86M 1.80M
Weighted Average Shares Outstanding (Diluted)
42.59M 10.27M 3.19M 2.86M 1.80M
Currency in USD

VYNE Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis